Full Archive

Battle of the Bulge

The "Bulge" was the largest and bloodiest single battle fought by the United States in World War II and the third-deadliest campaign in American history. – Wikipedia The current battle of the Bulge is between Lilly and Novo Nordisk as they battle it out in the excuse the expression expanding GLP-1 space. Yes, there are others Pfizer and Amgen quickly come to mind but for now it’s a battle between Lilly...

Not the answer

This morning Tandem announced that the FDA has approved their latest way cool whiz bang new toy the Mobi. Since the Street is fascinated by new toys and doesn’t understand how things really work shares of Tandem as we write are up over 14%, which isn’t saying much actually given how far shares have fallen. Here’s why the Mobi as interesting as it is – is NOT the answer for...

Heaven help us

Before the ADA began, I suggested a new award named after the late Al Mann. The Mann would be given to the stupidest study presented at ADA as we knew there would be a bunch. Therefore, I will start the nomination process with not one but two studies. The first published in The International Journal of Psychiatry in Medicine entitled Religion, Spirituality and Improved Glycemic Control Among People With Type...

Expanding our universe

Not sure who first coined the term Diabesity (Diabetes + Obesity) but it’s more appropriate than ever. The biggest news from ADA came on Monday when Lilly released results for their next gen obesity candidate Retatrutide. Even before that Lilly made news with their oral version of Trulicity. Not to be out done Novo Nordisk made news with their expanding obesity pipeline along with their once-weekly insulin. Dexcom and Abbott have...

ADA Final Impressions

This year’s version of the annual ADA confab was like past year’s versions full of both hope and trepidation. The data especially for the coming crop of weight loss meds was very compelling. As we predicted long ago not only is CGM becoming the standard for glucose measurement the usage of CGM is moving into the non-diabetic consumer health arena. Yet even with these advancements in drugs and devices one...

You don’t get a second chance at a first impression.

Not sure how many people remember when the 670G received FDA approval, but several organizations hailed the event calling it a new day in diabetes management. As the very first AID system approved by b the FDA everyone thought Medtronic had a runaway hit on their hands. That was everyone but us as we knew the 670G was NOT the best thing since sliced bread and soft soap. The major...

Is this progress?

Walking through the exhibit hall made me wonder what progress if any we have made over the past 30 years. Back then BGM was all the rage, today it’s CGM. Back then insulin pumps were new technology, today they are widely used. Insulins really haven’t changed all that much while the hottest thing today are diabetes drugs which also produce weight loss. The saddest lack of change comes where it...